Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism

MLA

Eiji Sasaki, et al. “Synergistic Antitumor Effect of Combined 5-Fluorouracil (5-FU) with 5-Chloro-2,4-Dihydroxypyridine on 5-FU-Resistant Gastric Cancer Cells: Possible Role of a Dihydropyrimidine Dehydrogenase-Independent Mechanism.” Journal of Gastroenterology, vol. 42, Oct. 2007, pp. 816–22. EBSCOhost, https://doi.org/10.1007/s00535-007-2101-5.

APA

Eiji Sasaki, Yasuhiro Fujiwara, Toshio Watanabe, Nobuhide Oshitani, Hikaru Kuwamura, Tetsuo Arakawa, Kazuhide Higuchi, & Kazunari Tominaga. (2007). Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism. Journal of Gastroenterology, 42, 816–822. https://doi.org/10.1007/s00535-007-2101-5

Chicago

Eiji Sasaki, Yasuhiro Fujiwara, Toshio Watanabe, Nobuhide Oshitani, Hikaru Kuwamura, Tetsuo Arakawa, Kazuhide Higuchi, and Kazunari Tominaga. 2007. “Synergistic Antitumor Effect of Combined 5-Fluorouracil (5-FU) with 5-Chloro-2,4-Dihydroxypyridine on 5-FU-Resistant Gastric Cancer Cells: Possible Role of a Dihydropyrimidine Dehydrogenase-Independent Mechanism.” Journal of Gastroenterology 42 (October): 816–22. doi:10.1007/s00535-007-2101-5.